Why You Should Know About Lynch Syndrome

Submitted by Dr S. Patel on 5 June 2018
Image: Stock photo of colon over white t-shirt and dark jeans set against a pink background

Colorectal cancer is the 4th most common cause of deaths related to cancer worldwide. Lynch syndrome or HNPCC is one of most common genetic causes of Colon cancer. Here are a few questions to better understand Lynch syndrome and how we can screen for it.

1. What is the Lynch syndrome? Which genes are involved?

Lynch Syndrome is also known as hereditary non-polyposis colorectal cancer or HNPCC. It has a genetic disposition, hence the term hereditary and is known to be associated or  the causative factor for various cancers including endometrial (second most common), ovarian, stomach, small intestine, hepatobiliary tract, upper urinary tract, skin and brain. It is an autosomal dominant genetic condition, which means that the gene defect can be passed down to the child even if only one parent has the mutated gene. Just one copy of the mutated gene is sufficient to develop cancer. Gene mutation is the permanent alteration in the DNA sequence that makes up a gene. Individuals who are carriers of such a mutated gene have a higher than normal chance of developing colorectal and the various cancers mentioned above, often at a young age. The early age onset, sporadic occurrence and right-sided colon lesions are discovered to be characteristic to Lynch syndrome. [Image result for lynch syndrome]

Genes currently known to be susceptible for Lynch syndrome include MLH1, MSH2, MSH6, PMS2, and EPCAM. 

2. What are signs and symptoms of Lynch syndrome?

It is recommended that one watch out for any signs and symptoms of colon and endometrial cancer. People with Lynch syndrome have the following risk factors:

  • Personal history of multiple gastrointestinal polyposis.
  • History of colon or gastrointestinal cancer at a younger age, especially before age of 50 years. 
  • Personal history of any of the following cancers: endometrial cancer, ovarian cancer, kidney cancer, stomach cancer, small intestine cancer, liver cancer, sweat gland cancer (sebaceous carcinoma), skin or brain.
  • Family history of colon or endometrial cancer under the age of 50.
  • 1 or more 1st or 2nd degree relative with colorectal or Lynch syndrome associated cancers. 
  • 2 or more 1st or 2nd degree relative with colorectal or Lynch syndrome associated cancers.

3. How common is the Lynch syndrome in India?

There are several inherited syndromes that can lead to increased risk of colon cancer, of which Lynch syndrome is the most common.

Statistics says that approximately 3 out of every 100 colon cancers are due by Lynch syndrome. In India, the annual incidence rate of Colon cancer is 4.4 per 100,000 in men and 3.9 per 100,000 in women. Approximately 5% of all colon cancers are attributed to genetic predisposition of Lynch syndrome.

4. Does Lynch syndrome affect every generation?

Yes. It does not skip generations. Both sexes can have Lynch syndrome and it may pass to any of their children.

5. How can a mother prevent passing on the gene to her child? How does preimplantation genetic diagnosis work for Lynch syndrome?

Mother can prevent passing unwanted genes to her child by doing preimplantation genetic diagnosis (PGD). Preimplantation genetic diagnosis is the procedure used to identify any genetic defects in an embryo. Embryos are usually made via the in vitro fertilization (IVF), tested at day 5 and only the desired embryos free of genetic problems are implanted into the uterus. Since the procedure is carried out before implantation, a couple has the choice of whether they want to start the pregnancy or not.

PGS or preimplantation genetic screening, is a procedure where all the embryos (produced by IVF) are checked for genetic diseases, so that the best embryo is then selected.

6. How is Lynch syndrome diagnosed?

After the tumor has been found via physical examination and colonoscopy, Lynch syndrome can be confirmed via tumor tissue testing from a biopsy. This is carried out for any individual who is suspected of having Lynch syndrome.

The two tumor tissue tests available are:

  • Microsatellite instability (MSI) test where a dye is used to check for missing proteins.
  • Immunohistochemistry (IHC) test determines instability in the DNA sequence.

Genetic testing of blood samples is commonly done to check for heritable mutations. Molecular genetic testing is necessary to confirm diagnosis of Lynch syndrome.

7. When and when should one start screening for it?

Families with Lynch syndrome and family members tested positive for gene mutation and those who have not been tested, should start colonoscopy screening during their early 20s, or 2 to 5 years younger than the youngest person in the family with a diagnosis (whichever is earlier). 

  • Colonoscopy should be done every 1 or 2 years. If there are any polyps present, they can be detected and removed. This helps find any early cancers too. People known to carry one of the gene mutations may also be given the choice of having surgery to remove most of the colon as a prophylactic measure.
  • Women are also recommended to inform their Gynecologist and get a transvaginal ultrasound or endometrial biopsy done every year after the age of 30.

8. If a person has been detected with the HPNCC genes, what preventive/ prophylactic measures are offered to the person?

  • Subtotal colectomy with ileorectal anastomosis (i.e. removal of subtotal colon and to join with rectum) and after that there is surveillance for rectum.
  • Or total colectomy with permanent ileostomy (removal of entire large colon and small bowel is put outside abdominal wall to pass stool and flatus permanently). This operation may be considered for prophylaxis in selected mismatch repair (MMR) gene mutation carriers.
  • Women may choose to have a hysterectomy (removal of the womb) or oophorectomy (removal of the ovaries). Such measures are recommended only after women have completed their families and do not prefer regular screening.

9. How much does genetic testing cost?

Testing of MLH1 is around 30,000/ rupees in India. If you have Lynch syndrome, each of your children have a 50% chance of acquiring the mutated gene. Children over the age of 18 can undergo genetic testing.

10. Can Lynch syndrome also cause Breast cancer?

The estimates of an increased risk of breast cancer in Lynch syndrome is relatively small compared with the increased risks observed for colorectal and endometrial cancers. 

It has a risk of around 12%.

11. What is the prognosis for Lynch syndrome-associated cancers?

Prognosis for Lynch Syndrome is,

  • Ten-year survival was 87% after any cancer.
  • 91% if the first cancer was colorectal.
  • 98% if endometrial and 89% if ovarian cancer..

References:

  1. Indian Council of Medical Research http://www.icmr.nic.in/guide/cancer/Colorectal/
  2. https://www.cancer.net/cancer-types/lynch-syndrome
  3. MedIndia, network for Health. https://www.medindia.net/patientinfo/lynch-syndrome.htm
  4. American Pregnancy Association. www.americanpregnancy.org

 

Community
Cancer
Condition
Breast Cancer
Cancer
Colorectal Cancer

Stories

  • Don't Believe the Hype - 10 Persistent Cancer Myths Debunked
    Driven by the evidence, not by rhetoric or anecdote, we describe what the reality of research actually shows to be true. Myth 1: Cancer is a man-made, modern disease While it’s certainly true that global lifestyle-related diseases like cancer are on the rise, the biggest risk factor for cancer is age. Myth 2: Superfoods prevent cancer Blueberries, beetroot, broccoli, garlic, green tea… the list goes on. Despite thousands of websites claiming otherwise, there’s no such thing…
  • Cambridge University finds gene behind killer disease - Triple negative breast cancer
    Triple-negative breast cancer is one of the most deadly forms of the disease, does not respond to hormonal therapies such as tamoxifen, or targeted drugs like Herceptin and nearly one quarter of patients diagnosed will not survive for more than five years. Now researchers at Cambridge University and the Wellcome Trust’s Sanger Institute have found that the BCL11A gene is overactive in eight out of ten patients. The study opens the door for therapies which suppress the gene and…
  • Goodbye Year of Cancer. Hello Hope!
    Death stared at me up close this year, says cancer survivor Minakshi Ray. What did that teach her about life? As I sit back and take stock of how 2014 treated me, I would say, it was a mixed bag. There have been losses and gains. I don't mean material losses or gains, rather I will remember the year in terms of the emotional journey. Following my battle of survival against breast cancer, my perspective on life has changed completely. The biggest realisation that has dawned…
  • Cancer survival rate in India among the lowest in the world
    Michael Coleman, professor at the London School of Hygiene and Tropical Medicine, and one of the lead authors of the study told TOI that one reason for the low survival rates in India could be that equitable access to early diagnosis and optimal treatment is not yet available for all people in India. "Some of the most advanced medical facilities in the world can be found in Mumbai (for example), but they are out of reach of the vast majority of the Indian population," he said. "The inequality…
  • How the promise of Immunotherapy is transforming Oncology
    Nine years later, against all odds, Mr. Telford is still alive. What saved him was an experimental immunotherapy drug—a medication that unleashes the body’s own immune system to attack cancer. His remarkable survival caught the attention of researchers, who began to realize that the way immunotherapy drugs were affecting tumors was unlike almost anything seen with conventional treatments. Today Mr. Telford is among a growing group of super-survivors who are transforming the world of…
  • 43% of Heart Attack Patients Had Anaemia
    India and South-east Asia has high incidence of anaemia. Family practitioner Dr Gita Mathai tells you all you need to know about this often-silent threat that can pose many complications.  What is anaemia? Anaemia (or Anemia) is a generic term for low haemoglobin in the blood from any cause. It is not a disease by itself. It can occur in different forms and be caused by many factors.  Anaemia is diagnosed when the haemoglobin value checked in the laboratory is…
  • Ananda Shankar Jayant : I want to be known not as a cancer survivor, but as a cancer conqueror
    Ananda Shankar Jayant talks of what inspired and gaver her strength to deal with Breast Cancer, its treatment, its aftermath "I realized then that I, who thought I had complete control of my life, had control of only three things: My thought, my mind -- the images that these thoughts created -- and the action that derived from it.  And I found that in my dance, my dance, my strength, my energy, my passion, my very life breath. But it wasn't easy. Believe me, it definitely wasn't easy…
  • Foods that fight cancer
    By nutritionist Kohila Govindaraju Being overweight has been linked with the increased risk of breast cancer, endometrial (uterus), and colorectal cancer. So keep your BMI at 25 or less with these foods that reduce your waist and your cancer risk: Fruits, vegetables, wholegrains and pulses are rich in vitamins and minerals, boosting your immune system. Go for dark coloured beans (rajma, brown beans, green beans, black-eyed beans) and brightly coloured vegetables and…
  • CYRAMZA now approved both as a single-agent treatment and in combination with chemotherapy
    The U.S. Food and Drug Administration (FDA) has approved CYRAMZA® (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy. CYRAMZA now has two FDA approvals for these patients. Today's announcement follows the April approval of CYRAMZA as a…
  • Smoking causes lung cancer and...17 other cancers including bladder cancer
    More than half of bladder cancers in the US are the result of smoking, and 90 per cent of smokers with the disease are aware of the connection, according to a new study. "Bladder cancer is actually the second most common smoking-related cancer, second only to lung," said lead author Dr. Jeffrey C. Bassett of Kaiser Permanente Southern California in Anaheim. Although previous studies had suggested that few people understood the connection between bladder cancer and tobacco, this new study found…